A history of preeclampsia identifies women who have underlying cardiovascular risk factors

Area of Science:

• Obstetrics and Gynecology
• Cardiology
• Reproductive Health

Background:

• Preeclampsia (PE) is a serious pregnancy complication.
• Identifying early cardiovascular disease (CVD) risk in women is crucial.
• Postpartum assessment of CVD risk in women with a history of PE is warranted.

Purpose of the Study:

• To prospectively evaluate physical and biochemical cardiovascular risk markers in women one year after developing preeclampsia (PE).
• To compare cardiovascular risk profiles between women with and without a history of PE.

Main Methods:

• Prospective cohort study comparing women with prior PE (n=70) to normotensive controls (n=70).
• Measurements included weight, blood pressure, fasting blood markers (insulin, glucose, C-reactive protein, lipids, cholesterol), and urine analysis (microalbumin, creatinine).
• Calculated Body Mass Index (BMI), Homeostatic Model Assessment (HOMA) index, and determined incidence of metabolic syndrome.

Main Results:

• Significant differences in cardiovascular disease markers were observed between the PE and normotensive groups at one year postpartum.
• A higher incidence of abnormal risk values was noted in women with a history of PE.
• Mathematical modeling indicated a 2- to 3-fold increased cardiovascular event risk associated with PE, particularly severe PE.

Conclusions:

• Development of preeclampsia serves as an early clinical marker for elevated cardiovascular disease risk in women.
• Women with a history of PE exhibit persistent cardiovascular risk factors postpartum.
• Early identification and monitoring of cardiovascular health in women with PE are essential for long-term well-being.